Tradestie Institutional Equity Comparison Engine

NVS vs NVO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NVO Overall Edge

NVO Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Novo-Nordisk A/S (NVO) driven by superior Valuation, Growth & Margin, Options & Structure while NVS counters with relative strength in Momentum & Technical. Fundamentally, NVS trades at 16.2x Forward P/E with 34.0% operating margin (+4.7% YoY revenue) versus NVO at 12.2x Forward P/E and 50.8% operating margin (+5.6% YoY). In options structure, NVS sits in UNCLASSIFIED (6th %ile IV; Dealer Gamma Walls on Pro) against NVO sits in CONSOLIDATION (25th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner NVO
NVS 16.2x vs NVO 12.2x Fwd P/E
Growth & Margin Winner NVO
Op Margin 34.0% vs 50.8% ยท YoY +4.7% vs +5.6%
Momentum & Technical Winner NVS
1Y +22.5% vs -15.2% ยท 52W Pos 81% vs 23%
Options & Structure Winner NVO
UNCLASSIFIED (6th %ile IV) vs CONSOLIDATION (25th %ile IV)
NVS NYSE
Novartis AG
Pharmaceutical Preparations
$161.59
+0.68% 1D
Market Cap $302.9B
1M Return +7.28%
1Y Return +22.5%
Forward P/E 16.2x
Unified AI Score
41.5 / 100 SELL
Tech 29.0 Fund 38.0 Flow 50.0 Mom 21.1
NVO NYSE
Novo-Nordisk A/S
Pharmaceutical Preparations
$41.71
+0.19% 1D
Market Cap $180.7B
1M Return +7.42%
1Y Return -15.15%
Forward P/E 12.2x
Unified AI Score
41.8 / 100 SELL
Tech 56.0 Fund 55.0 Flow 58.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NVS +22.5% NVO -15.15% Spread: +37.65 pp (NVS Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
NVS TTM Op. Margin: 34.0% NVO TTM Op. Margin: 50.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NVS vs NVO. Trailing 12-month operating profitability (NVS 34.0% vs NVO 50.8%) and valuation multiples (NVS 16.2x vs NVO 12.2x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NVS (3) vs NVO (7)
Institutional Metric NVS NVO Criterion Row Winner
Market Capitalization Scale $302.9B $180.7B Larger Scale NVS
Trailing P/E Ratio Valuation 30.6x 10.3x Lower Multiple NVO
Forward P/E Ratio Valuation 16.2x 12.2x Lower Multiple NVO
Revenue Growth (YoY) Growth +4.7% +5.6% Higher Growth NVO
Operating Margin (TTM) Profitability 34.0% 50.8% Higher Margin NVO
Net Profit Margin Profitability 17.5% 33.9% Higher Margin NVO
Return on Equity (ROE) Capital Efficiency 24.3% 58.4% Higher ROE NVO
52-Week Range Position Momentum 81% ($123โ€“$170) 23% ($35โ€“$64) Stronger Trend NVS
Beta / 30D Volatility Risk Regime 0.31ฮฒ ยท 27% Vol 0.50ฮฒ ยท 32% Vol Lower Realized Risk NVS
Unified Institutional Score Composite Signal 41.5 / 100 (SELL) 41.8 / 100 (SELL) Higher Composite NVO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NVS vs NVO Buy Guide
NVS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live NVS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NVO CONSOLIDATION
94d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 25th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live NVO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NVS nor NVO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.